Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA grants orphan drug designation to PPL's AAT for congenital deficiency

June 16, 1999

Schering-Plough prepares potent H3 antagonists for allergy, CNS disorders, etc.

June 16, 1999

Chemokine peptides designed at NeoRx useful for inflammatory disorders

June 15, 1999

Antiallergic phenothiazines patented by Eisai investigators

June 15, 1999

Array BioPharma designs series of potent and selective tryptase inhibitors

June 14, 1999

Effects of macrolide antibiotics on IL-8 release by eosinophils in asthma

June 14, 1999

Amgen reveals potent and selective typtase-inhibitory series

June 11, 1999

Cystic Fibrosis Foundation awards research grant to Genzyme

June 10, 1999

FDA says 3M's inhaled corticosteroid in CFC-free inhaler approvable for asthma

June 7, 1999

Kyowa Hakko presents new phosphodiesterase inhibitors

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...